Treatment of liver disorders with PI3K inhibitors
US8691829B2 · kind B2 · utility
12Cited by
45References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 21, 2010 |
| Grant date | Apr 8, 2014 |
| Priority date | — |
| Expiry date | Nov 14, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods to treat certain liver disorders by administering a compound that inhibits PD K isoforms, particularly the delta isoform. It further provides specific compounds useful for these methods and ways to identify subjects who are particularly suitable for receiving these treatments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.